Management Quality -- 7/10
Autoliv management earns a 7/10 based on excellent guidance accuracy across 6 quarters reviewed,
strong capital allocation (EPS +18% YoY, shares reduced ~15% since 2022, leverage at 1.1x), and
a clear strategic framework with measurable building blocks toward the 12% margin target. Withheld
from 8+ due to the 12% margin target becoming a multi-year moving target without a formal timeline
reset, persistent total-China underperformance despite repeated promises of improvement, and organic
growth mix effects that were not fully anticipated.
Weight: 20%
CEO / CFO Tenure
Bratt ~8yr / Westin ~7yr
No C-suite turnover during review period | CEO promoted from COO in 2018 | Strong strategic continuity
Promise Delivery
7 MET, 3 PARTIAL, 2 IN PROGRESS
12 promises tracked | Guidance accuracy among the best in auto supply | No miss exceeded a few percent
FY2025 Free Cash Flow
$734M (+48% YoY)
Cash conversion improved to 100% from 77% | OCF $1.157B | CapEx/sales declined to 4.5%
Adj. EPS Growth
$9.85 (+18% YoY)
EPS tripled over 5 years per management | Shares reduced ~15% since 2022 | Dividend raised 24% in 2025
Leadership team
Mikael Bratt -- President and CEO (~8 years, since 2018)
Long-tenured insider promoted from COO. Steady hand through COVID, inflation, and tariff cycles.
Architect of the 12% margin bridge framework with decomposed building blocks (indirect headcount,
call-off normalization, automation/digitalization). Delivers consistent, credible guidance with
specific quantitative targets. Managed proactive tariff response in Q1 2025 with surcharge
negotiations achieving 75-100% recovery intra-quarter.
Fredrik Westin -- CFO (~7 years, since 2019)
Disciplined financial communicator with consistent messaging on capital allocation. Oversaw
balance sheet management at 1.1x leverage (well below 1.5x target ceiling). Managed $2.44B
returned to shareholders over 5 years while maintaining investment-grade credit. Provides
clear, specific quantitative guidance on margins, cash flow, and capital deployment each quarter.
Anders Trapp -- VP, Investor Relations (multi-year)
Consistent presence on earnings calls. Professional IR function with transparent, quantified
communication on bridge components, headwinds, and strategic progress each quarter.
Tenure assessment
Both CEO and CFO have long, stable tenures with no C-suite turnover during the review period.
This is a positive signal for strategic continuity. The leadership team has been in place through
multiple macro cycles and has built institutional credibility with the investment community.
Promise vs. delivery tracker (12 promises)
| When Promised | Promise | Evidence | Grade |
|---|---|---|---|
| Q2 2024 | FY2024 adj. operating margin ~9.5-10% | Delivered 9.7% -- within guided range. | MET |
| Q3 2024 | FY2024 operating cash flow ~$1.1B | $1.059B actual -- slightly below but within rounding. | ROUGHLY MET |
| Q3 2024 | FY2024 organic sales growth ~1% | ~1% per transcripts. Revised from 2% and delivered. | MET |
| Q3 2024 | Indirect headcount -2,000 with $50M savings in 2024 | ~1,400 indirect reduced; $50M savings delivered per Q4 2024 call. | PARTIAL |
| Q4 2024 | FY2025 adj. operating margin ~10-10.5% | 10.3% actual -- mid-range of guidance. | MET |
| Q4 2024 / Q2 2025 | FY2025 organic sales growth ~3% (raised from ~2%) | ~3% confirmed in FY results. | MET |
| Q1 2025 | FY2025 operating cash flow ~$1.2B | $1.157B actual -- within reasonable margin. | ROUGHLY MET |
| Q3-Q4 2024 | CapEx trending to ~5% of sales and below | 4.5% in 2025 -- ahead of schedule. | MET |
| Q3-Q4 2024 | China: outperform LVP starting 2025 via COEM launches | COEM sales +23% FY2025, +40% Q4 2025; but total China underperformed by ~6pp due to mix. | PARTIAL |
| Ongoing | Medium-term target: ~12% adj. operating margin | 10.3% FY2025; 10.5-11% guided FY2026. Clear trajectory (9.7% to 10.3% to 10.5-11%). | IN PROGRESS |
| CMD Jun 2025 | $300-$500M annual share repurchases | $351M in FY2025 -- low end of range but within stated ambition. | MET |
| Q1 2025 | Tariff costs to be fully passed on to customers | ~75-80% recovered intra-quarter; ~100% by Q4. ~20bps margin dilution. | LARGELY MET |
Of 12 promises tracked, 7 were met or largely met, 2 were roughly met (within rounding), 2 were
partially delivered (headcount reduction and China outperformance), and 1 remains in progress (12%
margin target). No guidance miss exceeded a few percent. Guidance accuracy is among the best in
the auto supply sector.
Source: Daloopa, earnings call transcripts Q2 2024 - Q4 2025.
Quantitative scorecard (Daloopa)
| Metric | FY2024 | FY2025 | Change |
|---|---|---|---|
| Adj. Operating Margin | 9.7% | 10.3% | +60bps |
| Adj. Operating Income | $1,007M | $1,114M | +11% |
| Adj. EPS (Diluted) | $8.32 | $9.85 | +18% |
| Operating Cash Flow | $1,059M | $1,157M | +$98M |
| Free Cash Flow | $497M | $734M | +48% |
| Cash Conversion | 77% | 100% | +23pp |
| Gross Margin | 18.5% | 19.2% | +70bps |
| Headcount | 65,200 | 64,300 | -900 (on higher sales) |
Adj. operating margin expanded 60bps to 10.3%, with Q4 2025 hitting 12.0% (record quarter). Adj. EPS
grew 18% driven by margin expansion and share buybacks. Free cash flow nearly doubled to $734M with
cash conversion improving to 100%. Headcount declined 900 on higher sales, demonstrating operating
leverage. Quarterly margin trajectory: Q1 9.9%, Q2 9.3%, Q3 10.0% (record Q3), Q4 12.0%.
Data sourced from Daloopa.
Red flags check
| Flag | Status | Detail |
|---|---|---|
| Frequent guidance misses | NO | Consistently met guidance over the 6-quarter review period. |
| Earnings quality concerns | NO | Cash conversion of 100% in FY2025; FCF growth outpacing earnings growth. |
| C-suite turnover | NO | Stable CEO (8yr) and CFO (7yr). No unexpected departures. |
| Related-party transactions | NO | None identified in transcripts or filings. |
| Aggressive accounting | NO | Non-GAAP adjustments are small and well-explained (capacity alignment, antitrust). |
| Evasive on analyst questions | NO | Direct answers; quantifies components of guidance bridge; acknowledges headwinds openly. |
| Conflicting statements across calls | NO | Messaging is highly consistent quarter-to-quarter. |
| Excessive optimism / sandbagging | MILD | Slight tendency to set achievable guidance (sandbagging); 12% target timeline vaguely maintained without formal reset. |
| Supplier/customer concentration risk | MILD | BYD as captive competitor is structural; one supplier settlement ($40M) in 2024 disclosed transparently. |
Red flags detected: 0 major. 2 mild (slight sandbagging tendency with 12% target timeline not formally
reset, and BYD as structural captive competitor). Clean on accounting, capital allocation, transparency,
executive stability, and related-party concerns. No evasion on analyst questions.
Qualitative assessment
Consistent Guidance Accuracy
Over 6 quarters reviewed, management met or came very close to every quantitative guidance metric.
No guidance miss exceeded a few percent. They guided FY2024 margin at 9.5-10% and delivered 9.7%;
guided FY2025 at 10-10.5% and delivered 10.3%. This is a disciplined, credible team with guidance
accuracy among the best in the auto supply space.
Clear Strategic Framework
The 12% margin bridge is decomposed into: (a) ~80bps from indirect headcount reduction, (b) ~60bps
from call-off normalization/direct labor, (c) ~90bps from growth/automation/digitalization.
Management reports progress on each component every quarter with specific data -- headcount numbers,
call-off accuracy percentages, CapEx/sales. This transparency is above-average for the auto supply space.
Strong Capital Allocation
EPS tripled over 5 years. Outstanding shares reduced by ~15% since 2022. Leverage prudently managed
at 1.1x (well below 1.5x target ceiling). Dividend raised 24% in 2025. $2.44B returned to
shareholders over 5 years while maintaining investment-grade balance sheet. $590M returned in FY2025
alone. Capital allocation is shareholder-friendly and disciplined.
Proactive Tariff Management
Management acted quickly on tariffs in Q1 2025, establishing a task force and negotiating surcharges
intra-quarter. Recovery rates of 75-100% per quarter with only ~20bps margin dilution demonstrate
strong customer relationships and negotiating leverage. Close to full recovery by Q4 2025.
12% Margin Target Timeline Slippage
Originally framed around 2025-2026 achievability (based on ~85M LVP), the target is clearly now a
2027-2028 event at best. FY2026 is guided at 10.5-11%, still 100-150bps below target. Management
has not formally reset the timeline, which creates a credibility gap. They acknowledged the LVP
threshold assumption (85M) may need adjustment given structural mix shifts.
China Total-Market Underperformance
Despite strong COEM growth (+23% FY2025, +40% Q4 2025), total China underperformed by 6pp in
FY2025. The outperformance promise has been made since Q3 2024 and keeps getting pushed forward.
The COEM component delivers strongly (order intake share exceeding 40% vs. 25% installed), but
global-OEM weakness in China offsets it. This is a structural challenge they cannot fully control.
Score rationale
7/10. Autoliv management earns a solid 7 based on: (a) guidance accuracy that is
excellent -- among the best in auto supply, with every metric met or nearly met across 6 quarters,
(b) strong financial execution -- margins expanding (9.7% to 10.3%), EPS compounding at ~18%/yr,
FCF conversion at 100%, balance sheet strengthening despite significant capital returns, (c)
communication quality that is above average -- quantified bridge components, transparent on headwinds,
no evasion, (d) shareholder-friendly and disciplined capital allocation (leverage declining while
returning $590M in 2025), and (e) long CEO/CFO tenure providing continuity and accountability.
Why not 8+: The 12% margin target has become a multi-year moving target. While the building blocks are credible and progress is real, the lack of a firm timeline reset docks credibility. Total China performance remains a persistent miss despite repeated promises of improvement -- the COEM story is strong but the overall narrative has been over-promised. Organic growth outperformance was hampered by mix effects management did not fully anticipate (expected ~1pp negative mix, got ~4pp). Buyback pace was lumpy despite clear financial capacity.
What would move this to 8+: Formally resetting the 12% margin timeline with specific milestones. Delivering FY2026 at the high end of 10.5-11% guidance. Total China outperformance (not just COEM). Consistent buyback pace within the $300-500M range. Closing the gap to 12% with visible progress on all three bridge components. This is a solid, operationally disciplined management team executing well within their control in a difficult macro environment.
Why not 8+: The 12% margin target has become a multi-year moving target. While the building blocks are credible and progress is real, the lack of a firm timeline reset docks credibility. Total China performance remains a persistent miss despite repeated promises of improvement -- the COEM story is strong but the overall narrative has been over-promised. Organic growth outperformance was hampered by mix effects management did not fully anticipate (expected ~1pp negative mix, got ~4pp). Buyback pace was lumpy despite clear financial capacity.
What would move this to 8+: Formally resetting the 12% margin timeline with specific milestones. Delivering FY2026 at the high end of 10.5-11% guidance. Total China outperformance (not just COEM). Consistent buyback pace within the $300-500M range. Closing the gap to 12% with visible progress on all three bridge components. This is a solid, operationally disciplined management team executing well within their control in a difficult macro environment.
Data sourced from Daloopa and earnings call transcripts Q2 2024 - Q4 2025.